Swedbank AB lowered its stake in Markel Group Inc. (NYSE:MKL – Free Report) by 2.3% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,888 shares of the insurance provider’s stock after selling 44 shares during the period. Swedbank AB’s holdings in Markel Group were worth $2,961,000 as of its most recent filing with the SEC.
Other institutional investors also recently modified their holdings of the company. Toth Financial Advisory Corp increased its holdings in shares of Markel Group by 1,000.0% in the third quarter. Toth Financial Advisory Corp now owns 22 shares of the insurance provider’s stock valued at $35,000 after buying an additional 20 shares in the last quarter. UMB Bank n.a. increased its holdings in shares of Markel Group by 833.3% in the third quarter. UMB Bank n.a. now owns 28 shares of the insurance provider’s stock valued at $44,000 after buying an additional 25 shares in the last quarter. Point72 Asia Singapore Pte. Ltd. bought a new position in shares of Markel Group in the second quarter valued at $45,000. Thurston Springer Miller Herd & Titak Inc. bought a new position in shares of Markel Group in the second quarter valued at $55,000. Finally, Cubist Systematic Strategies LLC bought a new position in shares of Markel Group in the second quarter valued at $65,000. Institutional investors own 77.12% of the company’s stock.
Analyst Ratings Changes
Several analysts have issued reports on MKL shares. Royal Bank of Canada cut their target price on shares of Markel Group from $1,700.00 to $1,675.00 and set a “sector perform” rating on the stock in a research note on Friday, November 1st. Jefferies Financial Group boosted their target price on shares of Markel Group from $1,590.00 to $1,600.00 and gave the company a “hold” rating in a research note on Wednesday, October 9th. Finally, StockNews.com cut shares of Markel Group from a “buy” rating to a “hold” rating in a report on Wednesday. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a buy rating to the company. According to data from MarketBeat, Markel Group has a consensus rating of “Hold” and a consensus target price of $1,651.83.
Markel Group Trading Up 0.5 %
Markel Group stock opened at $1,785.11 on Thursday. The company’s fifty day simple moving average is $1,609.69 and its 200-day simple moving average is $1,589.29. The company has a quick ratio of 0.60, a current ratio of 0.60 and a debt-to-equity ratio of 0.26. Markel Group Inc. has a 12 month low of $1,342.66 and a 12 month high of $1,809.11. The stock has a market cap of $22.96 billion, a P/E ratio of 8.23 and a beta of 0.73.
Markel Group (NYSE:MKL – Get Free Report) last issued its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $17.34 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $21.97 by ($4.63). The business had revenue of $3.69 billion during the quarter, compared to the consensus estimate of $3.74 billion. Markel Group had a return on equity of 10.86% and a net margin of 17.03%. As a group, sell-side analysts forecast that Markel Group Inc. will post 88.52 EPS for the current fiscal year.
Markel Group Company Profile
Markel Group Inc, a diverse holding company, engages in marketing and underwriting specialty insurance products in the United States, Bermuda, the United Kingdom, and Germany. The company offers general and professional liability, personal lines, marine and energy, specialty programs, and workers' compensation insurance products; and property coverages that include fire, allied lines, and other specialized property coverages, including catastrophe-exposed property risks, such as earthquake and wind.
Read More
- Five stocks we like better than Markel Group
- 3 Fintech Stocks With Good 2021 Prospects
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Where to Find Earnings Call Transcripts
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Markel Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Markel Group and related companies with MarketBeat.com's FREE daily email newsletter.